Category Archives: Cardiovascular

Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry

Abstract Aspirin may be considered for primary prevention in non-elderly patients with high cardiovascular risk. However, contemporary management aimed at aggressive cardiovascular risk factor control may alter benefit-risk ratio of aspirin. Therefore, we aimed to examine the effect of aspirin for primary prevention on the long-term MACEs in a large cohort registry. Cohort Of patients […]

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study

Abstract We previously reported in the study of preventive effects of alogliptin on diabetic atherosclerosis (SPEAD-A) that alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, attenuated the progression of carotid atherosclerosis in subjects with type 2 diabetes and no history of cardiovascular disease. This extension study of the SPEAD-A trial investigated whether early alogliptin initiation improved long-term […]

Cardiovascular disease and all-cause mortality associated with individual and combined cardiometabolic risk factors

Study population China Hypertension Survey (CHS) is a nationally representative population-based study, which recruiting ~ 0.5 million participants from 31 provinces between October 2012 to December 2015 in mainland China. Design details were published previously [13,14,15]. This sub-study was based on CHS, and 16 cities and 17 counties were selected using a simple random sampling method from […]

MenaQ7 Vitamin K may offer heart protection in menopausal women

The RCT included the administration of Gnosis’ fermented vitamin K Menaquinone-7 (MK-7) supplement for a year-long intervention period in pre-, peri- and post-menopausal women aged 40-70 years, which observed significantly improved markers of vascular calcification and stiffness in all intervention groups. In post-menopausal women suffering from high vascular stiffness, this was found to be significantly […]

Leg Pain Due to Peripheral Artery Disease (PAD) May Curb Physical Activity, Increasing Risk for Depression

It can be a downward spiral. For people living with peripheral artery disease(PAD), leg pain is among the most common symptoms. When that pain interferes with how much these individuals walk, the likelihood that they will experience depression symptoms rises. So concludes a study recently published in Circulation: Cardiovascular Quality and Outcomes. The finding was […]

Sadayappan named executive director of the Center for Cardiovascular Research

Sadayappan notes that College of Medicine faculty currently hold 38 grants from the National Heart, Lung and Blood Institute to conduct various aspects of cardiovascular research. He sees that number quickly growing, in addition to increasing the number of federal training grants for young investigators. The College of Medicine currently holds two National Institutes of […]

Cardiovascular Drugs Market Share, Growth, Statistics, By Application, Production, Revenue & Forecast To 2023-2032 | Taiwan News

Global Overview of Cardiovascular Drugs Market The Cardiovascular Drugs Market research report plays an important role in running a successful business as it covers essential industry-related data. It is easy to make strategic decisions and allows you to monitor your business’s future growth and trends. We need an effective way to reach target consumers and […]

Saving Lives: The HEARTS Initiative in Saint Lucia

CHICAGO, Illinois — Saint Lucia is an island nation in the Eastern Caribbean. Home to a population of 180,000 Saint Lucians, the island is considered an upper middle-income economy, though it is still referred to as a developing nation. While Saint Lucia is on track to become one of the most developed countries in the Eastern Caribbean […]

PMC cardiovascular rehabilitation program certified by AACVPR

The Heart and Vascular Institute of Eastern Kentucky at Pikeville Medical Center has received certification of its cardiovascular rehabilitation program by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). This certification, according to a statement from PMC, is a recognition of PMC’s commitment to improving patients through quality care. The statement said cardiovascular and […]

No-React® cardiovascular bioprosthesis implantables: discontinuation of CE marking and manufacture. Remaining stock may continue to be used and any adverse incidents reported nationally (DSI/2023/009)

The MHRA emphasises the importance of national reporting of any suspected adverse incidents associated with the product following CE certification withdrawal and cease of manufacturing. Message type: Device safety information Medical specialty: Cardiology, Theatre practitioners, Vascular and cardiac surgery Issued: 4 September 2023 Contents Product details Background Actions for healthcare professionals Actions for patients Stakeholder […]